A review of moxidectin vs. other macrocyclic lactones for prevention of heartworm disease in dogs with an appraisal of two commercial formulations
Macrocyclic lactones (MLs) are the only drug class currently licensed for heartworm disease prophylaxis. Macrocyclic lactones kill third- and fourth-stage larvae of Dirofilaria immitis, thus preventing the development of adult worms in dogs, which are responsible for heartworm disease, a potentially...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2024-06-01
|
| シリーズ: | Frontiers in Veterinary Science |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fvets.2024.1377718/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|